+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • ID: 4851892
  • Report
  • March 2018
  • Region: Global
  • 229 pages
  • Transparency Market Research
1 of 2

Drug Discovery Informatics Market: Overview

This report on the Global Drug Discovery Informatics Market analyzes the current and future scenario of the global market.  Rise in private and public funding for drug discovery informatics, and increasing number of uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries, and to conduct their own preliminary analysis of interactions between the ligand and receptor are some of the factors expected to drive the growth of global Drug Discovery Informatics market during the forecast period.

The global Drug Discovery Informatics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments.  It also provides information and data analysis of the global market with respect to the segments based on of product, mode, function, end-user, and geography.  A detailed qualitative analysis of drivers and restraints, opportunities and trends have been provided in the market overview section.  Additionally, the section comprises Healthcare IT expenditure to help understand the scope in the market.  This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug discovery informatics market.  

Based on the product, the market is divided into development informatics, and discovery informatics. The discovery informatics segment dominated the market in terms of revenue in 2016, due to its cost benefits. Development informatics is anticipated to grow during the forecast period owing to the technological advancements in the development informatics. In terms of mode the market can be categorized into outsourced informatics, and in-house informatics. Outsourced informatics is estimated to dominate in terms of revenue in 2016 owing to the rise in collaborations and lead drug discovery projects between pharmaceutical companies, and IT market participants. In-house informatics is anticipated to grow in the coming years due to rise in the awareness regarding the time and cost benefits in the long run for the biotechnological and pharmaceutical companies.

Drug Discovery Informatics Market: Key Segments

Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modeling, and others. Sequencing and target data analysis is estimated to dominate the market in 2016, owing to reduced cost of sequencing informatics. Molecular modeling segment is anticipated to grow during the forecast period owing to the increasing number of applications of small molecules in drug discovery. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Contract research organizations (CROs) segment is estimated to dominate in 2016, owing to increasing number of CROs all over the world for drug discovery. Pharmaceutical and biotechnological companies segment is anticipated to grow during the forecast period owing to the long term time and cost benefits of the drug discovery informatics.

Geographically, the global drug discovery informatics market has been categorized into five major regions and the key countries in the respective region: North America (US  and Canada), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa).  

The report also profiles major players in the global drug discovery informatics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments.  Major players profiled in this report include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrödinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Segmentation
1.2. Key Research Objectives
1.3. Research Highlights

2. Assumptions

3. Research Approach & Methodology
3.1. Secondary Research Methodology
3.2. Primary Research Methodology
3.3. Analysis Research Methodology
3.4. Final Report & Conclusions Research Methodology

4. Executive Summary: Global Drug Discovery Informatics Market

5. Market Overview
5.1. Overview
5.2. Key Industry Events and Developments

6. Market Dynamics
6.1. Drivers and Restraints Snapshot Analysis
6.2. Drivers
6.3. Restraints
6.4. Opportunity
6.5. Key Trends
6.6. Healthcare IT spending, by Countries
6.6. Global Drug Discovery Informatics Market Forecast and Analysis
6.7. Global Drug Discovery Informatics Market Outlook

7. Global Drug Discovery Informatics Market Analysis and Forecasts, By Product
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast by Product, 2015-2025
7.3.1. Discovery Informatics
7.3.2. Development Informatics
7.4. Product Comparison Matrix
7.5. Market Attractiveness by Product

8. Global Drug Discovery Informatics Market Analysis and Forecasts, By Mode
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast by Mode, 2015-2025
8.3.1. In-House Informatics
8.3.2. Outsourced Informatics
8.4. Mode Comparison Matrix
8.5. Market Attractiveness by Mode

9. Global Drug Discovery Informatics Market Analysis and Forecasts, By Function
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast by Function, 2015-2025
9.3.1. Sequencing and Target Data Analysis
9.3.2. Docking
9.3.3. Lead Generation Informatics
9.3.4. Identification & Validation Informatics
9.3.5. Molecular Modeling
9.3.6. Others
9.4. Function Comparison Matrix
9.5. Market Attractiveness by Function

10. Global Drug Discovery Informatics Market Analysis and Forecasts, By End-User
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast by End-User, 2015-2025
10.3.1. Pharmaceutical & Biotechnology Companies
10.3.2. Contract Research Organizations
10.3.3. Others
10.4. End-User Comparison Matrix
10.5. Market Attractiveness by End-User

11. Global Drug Discovery Informatics Market Analysis and Forecasts, By Region
11.1. Global Drug Discovery Informatics Market Snapshot, by Country
11.2. Market Value Forecast by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness by Country/Region

12. North America Global Drug Discovery Informatics Market Analysis and Forecast
12.1. Key Findings
12.2. North America Global Drug Discovery Informatics Market Overview
12.3. Market Value Share Analysis by Product, 2015-2025
12.3.1. Discovery Informatics
12.3.2. Development Informatics
12.4. Market Value Share Analysis by Mode, 2015-2025
12.4.1. In-House Informatics
12.4.2. Outsourced Informatics
12.5. Market Value Share Analysis by Function, 2015-2025
12.5.1. Sequencing and Target Data Analysis
12.5.2. Docking
12.5.3. Lead Generation Informatics
12.5.4. Identification & Validation Informatics
12.5.5. Molecular Modeling
12.5.6. Others
12.6. Market Value Share Analysis by End-User, 2015-2025
12.6.1. Pharmaceutical & Biotechnology Companies
12.6.2. Contract Research Organizations
12.6.3. Others
12.7. Market Value Share Analysis by Country, 2015-2025
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Mode
12.8.3. By Function
12.8.4. By End-User
12.8.5. By Country
12.9. Market Trends

13. Europe Global Drug Discovery Informatics Market Analysis and Forecast
13.1. Key Findings
13.2. Europe Global Drug Discovery Informatics Market Overview
13.3. Market Value Share Analysis by Product, 2015-2025
13.3.1. Discovery Informatics
13.3.2. Development Informatics
13.4. Market Value Share Analysis by Mode, 2015-2025
13.4.1. In-House Informatics
13.4.2. Outsourced Informatics
13.5. Market Value Share Analysis by Function, 2015-2025
13.5.1. Sequencing and Target Data Analysis
13.5.2. Docking
13.5.3. Lead Generation Informatics
13.5.4. Identification & Validation Informatics
13.5.5. Molecular Modeling
13.5.6. Others
13.6. Market Value Share Analysis by End-User, 2015-2025
13.6.1. Pharmaceutical & Biotechnology Companies
13.6.2. Contract Research Organizations
13.6.3. Others
13.7. Market Value Share Analysis by Country, 2015-2025
13.7.1. Germany
13.7.2. France
13.7.3. Italy
13.7.4. Spain
13.7.5. UK
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Mode
13.8.3. By Function
13.8.4. By End-User
13.8.5. By Country
13.9. Market Trends

14. Asia Pacific Global Drug Discovery Informatics Market Analysis and Forecast
14.1. Key Findings
14.2. Asia Pacific Global Drug Discovery Informatics Market Overview
14.3. Market Value Share Analysis by Product, 2015-2025
14.3.1. Discovery Informatics
14.3.2. Development Informatics
14.4. Market Value Share Analysis by Mode, 2015-2025
14.4.1. In-House Informatics
14.4.2. Outsourced Informatics
14.5. Market Value Share Analysis by Function, 2015-2025
14.5.1. Sequencing and Target Data Analysis
14.5.2. Docking
14.5.3. Lead Generation Informatics
14.5.4. Identification & Validation Informatics
14.5.5. Molecular Modeling
14.5.6. Others
14.6. Market Value Share Analysis by End-User, 2015-2025
14.6.1. Pharmaceutical & Biotechnology Companies
14.6.2. Contract Research Organizations
14.6.3. Others
14.7. Market Value Share Analysis by Country, 2015-2025
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Mode
14.8.3. By Function
14.8.4. By End-User
14.8.5. By Country
14.9. Market Trends

15. Latin America Global Drug Discovery Informatics Market Analysis and Forecast
15.1. Key Findings
15.2. Latin America Global Drug Discovery Informatics Market Overview
15.3. Market Value Share Analysis by Product, 2015-2025
15.3.1. Discovery Informatics
15.3.2. Development Informatics
15.4. Market Value Share Analysis by Mode, 2015-2025
15.4.1. In-House Informatics
15.4.2. Outsourced Informatics
15.5. Market Value Share Analysis by Function, 2015-2025
15.5.1. Sequencing and Target Data Analysis
15.5.2. Docking
15.5.3. Lead Generation Informatics
15.5.4. Identification & Validation Informatics
15.5.5. Molecular Modeling
15.5.6. Others
15.6. Market Value Share Analysis by End-User, 2015-2025
15.6.1. Pharmaceutical & Biotechnology Companies
15.6.2. Contract Research Organizations
15.6.3. Others
15.7. Market Value Share Analysis by Country, 2015-2025
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Mode
15.8.3. By Function
15.8.4. By End-User
15.8.5. By Country
15.9. Market Trends

16. Middle East & Africa Global Drug Discovery Informatics Market Analysis and Forecast
16.1. Key Findings
16.2. Middle East & Africa Global Drug Discovery Informatics Market Overview
16.3. Market Value Share Analysis by Product, 2016-2025
16.3.1. Discovery Informatics
16.3.2. Development Informatics
16.4. Market Value Share Analysis by Mode, 2016-2025
16.4.1. In-House Informatics
16.4.2. Outsourced Informatics
16.5. Market Value Share Analysis by Function, 2016-2025
16.5.1. Sequencing and Target Data Analysis
16.5.2. Docking
16.5.3. Lead Generation Informatics
16.5.4. Identification & Validation Informatics
16.5.5. Molecular Modeling
16.5.6. Others
16.6. Market Value Share Analysis by End-User, 2016-2025
16.6.1. Pharmaceutical & Biotechnology Companies
16.6.2. Contract Research Organizations
16.6.3. Others
16.7. Market Value Share Analysis by Country, 2016-2025
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Mode
16.8.3. By Function
16.8.4. By End-User
16.8.5. By Country
16.9. Market Trends

17. Competition Landscape
17.1. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
17.1.1. Charles River Laboratories International, Inc.
17.1.1.1. Company Description
17.1.1.2. Financial Overview
17.1.1.3. Strategic Overview
17.1.1.4. Recent Developments
17.1.1.5. SWOT ANALYSIS
17.1.2. Thermo Fisher Scientific
17.1.2.1. Company Description
17.1.2.2. Financial Overview
17.1.2.3. Strategic Overview
17.1.2.4. Recent Developments
17.1.2.5. SWOT ANALYSIS
17.1.3. PerkinElmer Inc.
17.1.3.1. Company Description
17.1.3.2. Financial Overview
17.1.3.3. Strategic Overview
17.1.3.4. Recent Developments
17.1.3.5. SWOT ANALYSIS
17.1.4. Biogen Inc.
17.1.4.1. Company Description
17.1.4.2. Financial Overview
17.1.4.3. Strategic Overview
17.1.4.4. Recent Developments
17.1.4.5. SWOT ANALYSIS
17.1.5. Boehringer Ingelheim GmbH
17.1.5.1. Company Description
17.1.5.2. Financial Overview
17.1.5.3. Strategic Overview
17.1.5.4. Recent Developments
17.1.5.5. SWOT ANALYSIS
17.1.6. Insilico Medicine, Inc.
17.1.6.1. Company Description
17.1.6.2. Strategic Overview
17.1.6.3. SWOT ANALYSIS
17.1.7. International Business Machines Corporation
17.1.7.1. Company Description
17.1.7.2. Financial Overview
17.1.7.3. Strategic Overview
17.1.7.4. SWOT ANALYSIS
17.1.8. Schrödinger, LLC
17.1.8.1. Company Description
17.1.8.2. Strategic Overview
17.1.8.3. SWOT ANALYSIS
17.1.9. Albany Molecular Research Inc. (AMRI)
17.1.9.1. Company Description
17.1.9.2. Strategic Overview
17.1.9.3. SWOT ANALYSIS
17.1.10. Certara, L.P
17.1.10.1. Company Description
17.1.10.2. Strategic Overview
17.1.10.3. SWOT ANALYSIS
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll